CLINICAL_TRIALS
trial_result
· 2020-10-22
Clinical Trial Update: Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of a testosterone eye drop for Meibomian Gland Dysfunction has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ORA, Inc. | Conditions: Meibomian Gland Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2020-10-22